¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"surveillance bias"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • epidemiological surveillance
    ¿ªÇа¨½Ã
  • immune surveillance
    ¸é¿ª°¨½Ã
  • immunological surveillance
    ¸é¿ª°¨½Ã
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • post-marketing surveillance
    ½ÃÆÇÈĺÎÀÛ¿ë°¨½Ã
  • surveillance
    °¨½Ã, °¨µ¶
  • ascertainment bias
    È®ÀÎÄ¡¿ìħ
  • Berkson¡¯s bias
    ¹÷½¼Ä¡¿ìħ
  • bias
    Ä¡¿ìħ, Æí°ß, ¹ÙÀ̾
  • confounding bias
    ±³¶õÄ¡¿ìħ
  • constant bias
    »óÁ¸Ä¡¿ìħ
  • design bias
    ¼³°èÄ¡¿ìħ
  • detection bias
    °ËÃâÄ¡¿ìħ
  • information bias
    Á¤º¸Ä¡¿ìħ
  • interviewer bias
    Á¶»çÀÚÄ¡¿ìħ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • surveillance
    °¨½Ã
  • bias
    Ä¡¿ìħ, Æí°ß
  • Berkson's bias
    ¹÷½¼Ä¡¿ìħ
  • confounding bias
    ±³¶õÄ¡¿ìħ
  • detection bias
    °ËÃâÄ¡¿ìħ
  • information bias
    Á¤º¸Ä¡¿ìħ
  • interviewer bias
    Á¶»çÀÚÄ¡¿ìħ
  • memory bias
    ±â¾ïÄ¡¿ìħ
  • observer bias
    °üÂûÀÚÄ¡¿ìħ
  • recall bias
    ȸ»óÄ¡¿ìħ
  • selection bias
    ¼±ÅÃÄ¡¿ìħ, ¼±ÅÿÀÂ÷
  • selective survival bias
    ¼±ÅûýÁ¸Ä¡¿ìħ, ¼±ÅûýÁ¸¿ÀÂ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • surveillance data
    °ü¸®Á¤º¸Á¶»çÀÚ·á
  • epidemiological surveillance
    ¿ªÇа¨½Ã,
  • immune surveillance
    ¸é¿ª°¨½Ã
  • immunological surveillance
    ¸é¿ª°¨½Ã
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • post-marketing surveillance
    ½ÃÆÇÈĺÎÀÛ¿ëÁ¶»ç
  • surveillance
    °¨½Ã
  • surveillance
    ¿ªÇаü¸®Á¤º¸Á¶»ç
  • ascertainment bias
    È®ÀιÙÀ̾
  • bias
    ¹ÙÀ̾, Ä¡¿ìħ
  • constant bias
    »óÁ¸ÆíÀç
  • design bias
    ¼³°è¹ÙÀ̾
  • detection bias
    ¹ß°ß¹ÙÀ̾
  • information bias
    Á¤º¸¹ÙÀ̾
  • interviewer bias
    Á¶»çÀÚ¹ÙÀ̾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • analyltical bias
    ºÐ¼®Æí°ß
  • proportional bias
    ºñ·ÊÆíÀç(ÝïÖÇø¶î¤)
  • PMS : post marketing surveillance
    ½ÃÆÇÈÄ ºÎÀÛ¿ëÁ¶»ç.
  • immune surveillance
    ¸é¿ª°¨½Ã
  • immune surveillance
    ¸é¿ª[ÇÐÀû]°¨½Ã±âÀü
  • immunologic surveillance
    ¸é¿ª°¨½Ã(±â±¸).
  • immunological surveillance
    ¸é¿ª°¨½Ã(±â±¸)(ÊÙ˧Ëà˻˴), ¸é¿ªÁ¶»ç.
  • immunological surveillance
    ¸é¿ª°¨½Ã(±â±¸)(¡­ÊøãÊѦϰ), ¸é¿ªÁ¶»ç.
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • post marketing surveillance
    ½ÃÆÇÈÄ ºÎÀÛ¿ëÁ¶»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • analyltical bias
    ºÐ¼®Æí°ß
  • bias
    Æí°ß
  • bias
    Ä¡¿ìħ, ¹ÙÀ̾, ÆíÀç
  • constant bias
    »óÁ¸(¼º)ÆíÀç
  • proportional bias
    ºñ·ÊÆíÀç(ÝïÖÇø¶î¤)
  • selection bias
    ¼±ÅÃ(¼±¹ß, ¼±Á¤)¿ÀÂ÷
  • selective attrition bias
    ¼±ÅÃÀû ¼Õ½Ç¿ÀÂ÷
  • epidemiological surveillance
    ¿ªÇÐÀû °¨½Ã(ËçÌ°ËøË§Ëà), ¿ªÇÐÀû °ü¸®Á¤º¸Á¶ »ç.
  • immune surveillance
    ¸é¿ª[ÇÐÀû]°¨½Ã±âÀü
  • immune surveillance
    ¸é¿ª°¨½Ã
  • immunologic surveillance
    ¸é¿ª°¨½Ã(±â±¸).
  • immunological surveillance
    ¸é¿ª°¨½Ã(±â±¸)(¡­ÊøãÊѦϰ), ¸é¿ªÁ¶»ç.
  • immunological surveillance
    ¸é¿ª°¨½Ã(±â±¸)(ÊÙ˧Ëà˻˴), ¸é¿ªÁ¶»ç.
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • post marketing surveillance
    ½ÃÆÇÈÄ ºÎÀÛ¿ëÁ¶»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune surveillance theory
    ¸é¿ª °¨½Ã ÀÌ·Ð(Øóæ¹ÊøãÊ×âÖå)
  • immunological surveillance theory
    ¸é¿ª °¨½Ã ÀÌ·Ð(Øóæ¹ÊøãÊ×âÖå)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bias
    Ä¡¿ìħ, ¹ÙÀ̾, ÆíÀç, ºñƲ¸²
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BCDSP Boston Collaborative Drug Surveillance Program
CDSC Communicable Diseases Surveillance Centre [London]
COMPASS Computerized Online Medicaid Pharmaceutical Analysis and Surveillance System
CSS Cancer Surveillance System; carotid sinus stimulation; carotid sinus syndrome; cavernous sinus syndr...
CWXSP Coal Workers' X-ray Surveillance Program
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
B bias
ABLES Adult Blood Lead Epidemiology and Surveillance program
BRFSS Behavioral Risk Factor Surveillance System
CDSC Communicable Disease Surveillance Centre
NEISS National Electronic Injury Surveillance System
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bias
    Ä¡¿ìħ, ¹ÙÀ̾, ÆíÀç
    ü°èÀûÀÎ °ú¿À, ÃßÁ¤ÀÚÀÇ ¿¹ÃøÄ¡¿Í ÆÄ¶ó¹ÌÅÍÄ¡ »çÀÌÀÇ ¿ÀÂ÷.
  • epidemiological surveillance
    ¿ªÇÐÀû °¨½Ã
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
bias <statistics> In a clinical trial, bias refers to effects that a conclusion that may be incorrect as, for example, when a researcher or patient knows what treatment is being given. To avoid bias, a blinded study may be done.
Any deviation of results or inferences from the truth, or processes leading to such deviation.
Bias can result from several sources: one-sided or systematic variations in measurement from the true value (systematic error); flaws in study design; deviation of inferences, interpretations, or analyses based on flawed data or data collection; etc. There is no sense of prejudice or subjectivity implied in the assessment of bias under these conditions.
(27 Jun 1999)
publication bias The influence of study results on the chances of publication and the tendency of investigators, reviewers, and editors to submit or accept manuscripts for publication based on the direction or strength of the study findings. Publication bias has an impact on the interpretation of clinical trials and meta-analyses. Bias can be minimised by insistence by editors on high-quality research, thorough literature reviews, acknowledgement of conflicts of interest, modification of peer review practices, etc.
(12 Dec 1998)
selection bias The introduction of error due to systematic differences in the characteristics between those selected and those not selected for a given study. In sampling bias, error is the result of failure to ensure that all members of the reference population have a known chance of selection in the sample.
(12 Dec 1998)
insurance selection bias Adverse of favourable selection bias exhibited by insurers or enrollees resulting in disproportionate enrollment of certain groups of people.
(12 Dec 1998)
internal bias Applied to the motile behaviour of crawling cells that, in the short term, show persistence and do not behave as true random walkers. Any intrinsic regulation of the random motile behaviour of the cell could be considered as internal bias.
(18 Nov 1997)
cancer, colon: screening and surveillance Colon cancer is both preventable and curable. It is preventable by removing precancerous colon polyps. It is curable if early cancer is surgically removed before cancer spread to other parts of the body. Therefore, if screening and surveillance programs were practiced universally, there would be a major reduction in the incidence and mortality of colon cancer.
(12 Dec 1998)
population surveillance <epidemiology> Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.
(12 Dec 1998)
post-marketing surveillance Procedure implemented after a drug has been licensed for public use, designed to provide information on use and on occurrence of side effects, adverse effects, etc.
(05 Mar 2000)
product surveillance, postmarketing Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale.
(12 Dec 1998)
sentinel surveillance Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort, geographic area, population subgroup, etc. To estimate trends in larger population.
(12 Dec 1998)
surveillance Oversight; watch; inspection; supervision. "That sort of surveillance of which . . . The young have accused the old." (Sir W. Scott)
Origin: F, fr. Surveiller to watch over; sur over + veiller to watch, L. Vigilare. See Sur-, and Vigil.
Source: Websters Dictionary
(01 Mar 1998)
immune surveillance <immunology> The hypothesis that lymphocyte traffic ensures that all or nearly all parts of the vertebrate body are surveyed by visiting lymphocytes in order to detect any altered self material, for example mutant cells.
(18 Nov 1997)
immunological surveillance <immunology> The hypothesis that lymphocyte traffic ensures that all or nearly all parts of the vertebrate body are surveyed by visiting lymphocytes in order to detect any altered self material, for example mutant cells.
(18 Nov 1997)
immunologic surveillance The theory that T-cells monitor cell surfaces and detect structural changes in the plasma membrane and/or surface antigens of virally or neoplastically transformed cells.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bias
    »ç¼±
  • surveillance
    °¨½Ã; °¨µ¶
  • bias
    »ç¼±;¹ÙÀ̾;°æ»ç;°æÇâ;¼ºº®-±â¿ïÀÌ´Ù;Ä¡¿ìÄ¡°ÔÇÏ´Ù;Æí°ßÀ» °®´Ù
  • electronic surveillance
    ÀüÀÚ °¨½Ã(Á¤º¸ ¼öÁý)
  • forward bias
    ¼ø ¹ÙÀ̾(¹ÝµµÃ¼ ¼ÒÀÚ¿¡ Àü·ù°¡ È帣´Â ¹æÇâÀ¸·Î °Å´Â)
  • grid bias
    ±×¸®µå ¹ÙÀ̾
  • immune surveillance
    IMMUNOLOGICAL SURVEILLANCE
  • surveillance
    °¨½Ã;°¨µ¶;under ~ °¨µ¶À» ¹Þ°í
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á